Liquidia (LQDA) is down -9.5%, or -$3.29 to $31.20.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LQDA:
- Liquidia Technologies call volume above normal and directionally bullish
- Liquidia’s Phase 3 Study: Pioneering Treatment for Pulmonary Hypertension
- Liquidia Technologies’ Earnings Call: Success Amid Challenges
- Liquidia price target raised to $50 from $35 at H.C. Wainwright
- Positive Outlook for Liquidia Technologies: Strong Financial Performance and Growth Prospects Justify Buy Rating
